Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
11.18
-0.08 (-0.75%)
At close: May 9, 2025, 4:00 PM
11.18
0.00 (0.00%)
After-hours: May 9, 2025, 4:01 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $161.77 million as of May 9, 2025.
Market Cap
161.77M
Enterprise Value
17.22M
1-Year Change
n/a
Ranking
Category
Stock Price
$11.18
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has decreased from $198.24M to $161.77M, a decrease of -18.40%. That is a compound annual growth rate of -19.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 163.00M | -26.88% |
| Dec 31, 2024 | 222.93M | 12.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 349.75B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |